Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation von Burghard, M (Marcella), Berkers, G (Gitte), Ghijsen, S (Sophie), Hollander‐Kraaijeveld, FM (Francis), Winter‐de Groot, KM (Karin), Ent, CK (Kors), Heijerman, HGM (Harry), Takken, T (Tim), Hulzebos, HJ (Erik)

Volltext

Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer ®) for high powder doses von de Boer, Anne H., Hagedoorn, Paul, Westerman, Elsbeth M., Le Brun, Paul P.H., Heijerman, Harry G.M., Frijlink, Henderik W.

Volltext

Birth prevalence and survival in cystic fibrosis : A national cohort study in the Netherlands von SLIEKER, Martijn G, UITERWAAL, Cuno S. P. M, SINAASAPPEL, Maarten, HEIJERMAN, Harry G. M, VAN DER LAAG, Johan, VAN DER ENT, Cornelis K

Volltext

Outcome of assisted ventilation for acute respiratory failure in cystic fibrosis von SLIEKER, Martijn G, VAN GESTEL, Josephus P. J, HEIJERMAN, Harry G. M, TRAMPER-STRANDERS, Gerdien A, VAN BERKHOUT, Ferdinand Teding, VAN DER ENT, Cornelis K, JANSEN, Nicolaas J. G

Volltext

Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients von Scheenstra, Renske J., Rijntjes, Evert, Tavy, Dénes L.J., Kingma, Herman, Heijerman, Harry G.M.

Volltext

Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressor von Westerman, Elsbeth M, Boer, Anne H De, Touw, Daan J, Brun, Paul P H Le, Roldaan, Albert C, Frijlink, Henderik W, Heijerman, Harry G M

Volltext

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment : clinical outcome, microbiology and pharmacokinetics von VINKS, A. A. T. M. M, BRIMICOMBE, R. W, HEIJERMAN, H. G. M, BAKKER, W

Volltext

A Cystic Fibrosis Mutation Associated with Mild Lung Disease von Gan, King-Han, Veeze, Henk J, van den Ouweland, Ans, Halley, Dicky, Scheffer, Hans, van der Hout, Annemieke, Overbeek, Shelley E, de Jongste, Johan C, Bakker, Willem, Heijerman, Harry

Volltext

Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years von Gan, K H, Geus, W P, Bakker, W, Lamers, C B, Heijerman, H G

Volltext

To the editor: Adverse effects of ceftazidime treatment von Döring, Gerd, Heijerman, Harry G.M.

Volltext

Can tobramycin inhalation be improved with a jet nebulizer? von LE BRUN, P. P. H, VINKS, A. A. T. M. M, TOUW, D. J, HEKELAAR, N, MANNES, G. P. M, BRIMICOMBE, R. W, FRIJLINK, E. H. W, HEIJERMAN, H. G. M

Volltext

Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategy von VINKS, A. A. T. M. M, MOUTON, J. W, TOUW, D. J, HEIJERMAN, H. G. M, DANHOF, M, BAKKER, W

Volltext

Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home von VINKS, A. A. T. M. M, TOUW, D. J, HEIJERMAN, H. G. M, DANHOF, M, DE LEEDE, G. P. J, BAKKER, W

Volltext

Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas von HEIJERMAN, H. G. M, LAMERS, C. B. H. W, BAKKER, W, DIJKMAN, J. H

Volltext

Photosensitivity due to ambulatory intravenous ceftazidime in cystic fibrosis patient von Vinks, SanderA.T.M.M., Heijerman, HarryG.M., De Jonge, Paul, Bakker, Willem

Volltext

Pharmacodynamic and pharmacokinetic optimisation of treatment with beta -lactam antibiotics in cystic fibrosis von Vinks, AATMM, Mouton, J W, Heijerman, HGM, Bakker, W

Volltext